ArticleResearch in pharmaceutical sciences2026
Development of a recombinant biosimilar single-chain variable fragment antibody targeting human estrogen receptor α36.
Soodabeh Shafiee et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.